Discovery of Potent, Selective, Orally Active, Nonpeptide Inhibitors of Human Mast Cell Chymase
Journal of Medicinal Chemistry2007Vol. 50(8), pp. 1727–1730
Citations Over TimeTop 19% of 2007 papers
Michael N. Greco, Michael Hawkins, Eugene T. Powell, Harold R. Almond, Lawrence de Garavilla, Jeffrey Hall, Lisa Minor, Yuanping Wang, Thomas W. Corcoran, Enrico Di, Angelene M. Cantwell, Savvas N. Savvides, Bruce P. Damiano, Bruce E. Maryanoff
Abstract
A series of beta-carboxamido-phosphon(in)ic acids (2) was identified as a new structural motif for obtaining potent inhibitors of human mast cell chymase. For example, 1-naphthyl derivative 5f had an IC50 value of 29 nM and (E)-styryl derivative 6g had an IC50 value of 3.5 nM. An X-ray structure for 5f.chymase revealed key interactions within the enzyme active site. Compound 5f was selective for inhibiting chymase versus eight serine proteases. Compound 6h was orally bioavailable in rats (F=39%), and orally efficacious in a hamster model of inflammation.
Related Papers
- → Bovine mast cells: distribution, density, heterogeneity, and influence of fixation techniques(1998)54 cited
- Mast cell proteases in immunology and biology(1995)
- → Mast cell granule composition and tissue location--a close correlation.(2000)34 cited
- → Mast Cell Chymase Regulates Dermal Mast Cell Number in Mice(2002)29 cited
- → The major enzymes of human mast cell secretory granules.(1987)42 cited